National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -5 of 5         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


PTH-302
NCT00080080


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


PTH-301
NCT00083239


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Completed


18 and over


Pharmaceutical / Industry


PTH-303
NCT00083252


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Closed


18 and over


Pharmaceutical / Industry


PTH-203
FD-R-003021-01, NCT00086203

Last Modified: 12/13/2007     First Published: 3/13/2006  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Treatment


Temporarily closed


2 to 18


NCI


NCI-05-C-0239
NCI-P6672, NCT00303940

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov